Earnings History Data for Apellis Pharmaceuticals, Inc. (APLS) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Apellis Pharmaceuticals, Inc.

Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade. Apellis Pharmaceuticals, Inc. is based in CRESTWOOD, United States.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
09-08-2021 AH 4:00 PM ET
(Aug 9)
APLS Apellis Pharmaceuticals, Inc. 5,590 -2.72 -1.70 -1.57 Apellis Pharmaceuticals EPS misses by $1.03, beats on revenue
[8/9/2021 4:19 PM]
59.90 -2.10 
(-3.40%)
62.00 0.0 
(0.00%)
26.38 - 73.00 615,635 720,000 196,848
28-04-2021 AH 4:00 PM ET
(Apr 28)
APLS Apellis Pharmaceuticals, Inc. 3,630 -2.32 -1.69 -2.29 Apellis Pharmaceuticals EPS misses by $0.69
[4/28/2021 4:03 PM]
48.39 3.09 
(6.82%)
45.30 0.0 
(0.00%)
25.49 - 58.47 721,832 580,000 9,920
25-02-2021 AH 4:10 PM ET
(Feb 25)
APLS Apellis Pharmaceuticals, Inc. 3,660 0.93 -0.47 -1.70 Apellis Pharmaceuticals EPS beats by $1.38, beats on revenue
[2/25/2021 4:02 PM]
48.37 3.32 
(7.37%)
46.20 1.15 
(2.55%)
16.85 - 58.47 611,867 465,679 7,943
02-11-2020 PM APLS Apellis Pharmaceuticals, Inc. 2,410 -1.79 -1.53 -1.10 Apellis Pharmaceuticals EPS misses by $0.21
[11/2/2020 7:14 AM]
36.95 3.48 
(10.40%)
33.47 0.0 
(0.00%)
16.85 - 45.04 983,650 547,945 11,746